AMS signs development deal

14:26 EDT 10 Oct 2017 | BioNow

Winsford medical technology company Advanced Medical Solutions Group (AMS) has agreed a development deal with Surgical Innovations Group.The agreement covers the development and supply of a novel device for internal application of adhesives and sealants.Leeds-based Surgical Innovations will develop and retain the intellectual property rights for the device while AMS - in return for the worldwide exclusive rights to this applicator - has agreed to purchase all of its requirements for the approved new applicator from Surgical Innovations for a period of ten years.AMS has indicated that the first target internal application will be the hernia mesh fixation market.AMS chief executive Chris Meredith added "This agreement combines our formulation and regulatory expertise with Surgical Innovations' applicator design and manufacturing expertise to introduce a new product to a global market for internal sealants that is now in excess of $600m."Surgical Innovations chief executive Graham Bowland added "Our agreement with AMS affirms SI's reputation in delivering leading design solutions to OEM customers."The applicator device for AMS is a natural extension to our existing minimally invasive surgical product portfolio and we have already commenced on the design work on a fully disposable product."As part of the agreement SI will retain the full intellectual property rights to the applicator device and will also manufacture it on behalf of AMS."

Original Article: AMS signs development deal


More From BioPortfolio on "AMS signs development deal"

Quick Search


Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...